Search clinical trials for: Claudin 18.2
Total 103 results
-
PfizerTerminatedHemophilia AUnited States, New Zealand
-
Suzhou Immunofoco Biotechnology Co., LtdChanghai HospitalRecruitingGastric Cancer | Pancreatic Cancer | Gastroesophageal Junction Adenocarcinoma | Advanced Ovarian CarcinomaChina
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingRhabdomyosarcoma | Desmoplastic Small Round Cell TumorUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic SyndromeUnited States
-
Cairo UniversityUnknown
-
TORL Biotherapeutics, LLCTranslational Research in OncologyRecruitingGastric Cancer | Advanced Solid Tumor | Pancreas Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States
-
TORL Biotherapeutics, LLCTranslational Research in OncologyRecruitingGastric Cancer | Advanced Solid Tumor | Pancreas Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States
-
Triumvira Immunologics, Inc.RecruitingMetastatic Solid TumorUnited States, Canada
-
Suzhou Immunofoco Biotechnology Co., LtdRecruitingAdvanced Digestive System TumorChina
-
Shanghai Zhongshan HospitalRecruitingBiliary Tract Cancer | Candonilimab | Claudin 18.2China
-
Biotheus Inc.RecruitingAdvanced TumorChina
-
The Affiliated Hospital of Qingdao UniversityRecruiting
-
Astellas Pharma Global Development, Inc.Not yet recruitingClaudin 18.2 (CLDN18.2) Positive Metastatic Pancreatic Adenocarcinoma
-
CARsgen Therapeutics Co., Ltd.Shanghai East HospitalCompletedGastric Cancer | Pancreatic Adenocarcinoma | Solid TumorChina
-
Conjupro Biotherapeutics, Inc.CSPC Megalith Biopharmaceutical Co., Ltd.WithdrawnGastric Cancer | Pancreatic Cancer
-
Peking UniversityCARsgen Therapeutics Co., Ltd.RecruitingPancreatic Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaChina
-
Peking UniversityGracell Biopharmaceuticals, Inc.RecruitingGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaChina
-
Astellas Pharma Global Development, Inc.RecruitingPancreatic Adenocarcinoma | Gastric Adenocarcinoma | Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Japan, Korea, Republic of
-
AstraZenecaRecruitingGastric Cancer | Gastroesophageal Junction CancerCanada, Spain, United Kingdom, China, France, Italy, Vietnam, Germany, United States, India, Taiwan, Thailand, Hong Kong, Japan, Switzerland, Poland
-
CARsgen Therapeutics Co., Ltd.Fudan UniversityRecruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingPancreatic Cancer | Advanced Solid Tumor | Gastric Cancer (GC) | Gastroesophageal Junction (GEJ) CancerChina
-
AstraZenecaRecruitingGastric Cancer | Pancreatic Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Spain, United Kingdom, Korea, Republic of, Japan, Taiwan, Malaysia, Canada, Singapore, Moldova, Republic of, Australia, Georgia
-
Flame BiosciencesWithdrawnGastric Cancer | Solid Tumor | Pancreas Cancer
-
Peking UniversityCARsgen Therapeutics Co., Ltd.Completed
-
AskGene Pharma, Inc.Jiangsu Aosaikang Pharmaceutical Co., Ltd.RecruitingGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaChina
-
University of BernCompletedDental Implant Failed | Jaw, Edentulous, Partially | Implant ComplicationSwitzerland
-
Legend Biotech USA IncRecruitingGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Gastroesophageal-junction CancerUnited States
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingPancreatic Cancer | Metastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States, Korea, Republic of, Japan, China, France, Turkey, Italy, Australia, Brazil, Ireland, Mexico, Spain, Taiwan
-
Second Affiliated Hospital of Guangzhou Medical...Guangdong Zhaotai InVivo Biomedicine Co. Ltd.; Hunan Zhaotai Yongren Medical...RecruitingCancer | Lung Cancer | Immunotherapy | CAR-T CellChina
-
CARsgen Therapeutics Co., Ltd.Fudan University; Peking University Cancer Hospital & InstituteRecruitingStudy to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell InjectionPancreatic Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaChina
-
Ralf HofheinzInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Deutsche... and other collaboratorsRecruiting
-
University of Erlangen-Nürnberg Medical SchoolChiesi Farmaceutici S.p.A.Completed
-
AstraZenecaRecruitingGastric Cancer | Pancreatic Ductal Adenocarcinoma | Esophageal Adenocarcinoma | Gastro-esophageal Junction CancerKorea, Republic of, United States, Japan, Taiwan, China, United Kingdom, Netherlands
-
FutureGen Biopharmaceutical (Beijing) Co., LtdRecruitingLocally Advanced Unresectable or Metastatic Gastric Cancer | Locally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingUnresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaChina
-
Astellas Pharma Global Development, Inc.AvailableMetastatic Gastroesophageal Junction (GEJ) Adenocarcinoma | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma Cancer | Metastatic Gastric Adenocarcinoma CancerUnited States, Germany
-
Astellas Pharma Global Development, Inc.RecruitingGastric Cancer | Pharmacokinetics of Zolbetuximab | Gastro-esophageal Junction (GEJ) Cancer | Pharmacokinetics of Oxaliplatin | Pharmacokinetics of Fluorouracil Bolus (5-FU)United States, Japan, Italy, Korea, Republic of, Taiwan, France
-
Sylvie NadeauRecruitingAging | Mobility LimitationCanada
-
LaNova Medicines Zhejiang Co., Ltd.Not yet recruitingLocally Advanced or Metastatic GC and GCJ Adenocarcinoma
-
Institut de Médecine et d'Epidémiologie Appliquée...Institut National de la Santé Et de la Recherche Médicale, France; Saint-Louis... and other collaboratorsNot yet recruiting
-
Centre Hospitalier William Morey - Chalon sur SaôneCentre Hospitalier Universitaire DijonRecruitingCritically Ill | Central Venous Catheter Associated Bloodstream Infection | Healthcare Associated InfectionFrance
-
Institut National de Recherche pour l'Agriculture...RecruitingNon Dependant 60 to 75 Year-old Men and WomenFrance
-
ANRS, Emerging Infectious DiseasesProgramme PAC-CI; Centre Population et Développement (CEPED/IRD)Recruiting
-
University of NimesNot yet recruitingWellbeing | Emotional Distress | Psychosocial Problem | Functional Impairment | User ExperienceFrance
-
Alentis Therapeutics AGRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Hong Kong, Singapore, Spain, Canada, Italy
-
Bristol-Myers SquibbRecruitingMyelodysplastic SyndromesSpain, United States, France, Italy, Belgium, Germany, Poland, Czechia, Puerto Rico
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruiting
-
ViiV HealthcareGlaxoSmithKline; PPDRecruitingHIV InfectionsUnited States, Italy, Spain, Argentina, Germany, France, Canada, Chile, Puerto Rico